title: An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
authors.affiliation: National Institute of Immunohaematology (ICMR), KEM Hospital, Parel, Mumbai, 400 012, India.
authors.forename: Priyanka
authors.initials: P
authors.lastname: Kasatkar
authors.forename: Kanjaksha
authors.initials: K
authors.lastname: Ghosh
authors.forename: Shrimati
authors.initials: S
authors.lastname: Shetty
mesh_terms: D000918:Antibody Specificity; D001323:Autoantibodies / Q000096:biosynthesis* / Q000276:immunology; D003937:Diagnosis, Differential; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010314:Partial Thromboplastin Time; D010974:Platelet Aggregation / Q000187:drug effects; D011239:Prednisolone / Q000627:therapeutic use; D011517:Prothrombin Time; D012310:Ristocetin / Q000494:pharmacology; D055815:Young Adult; D014842:von Willebrand Diseases / Q000097:blood / Q000209:etiology*; D014841:von Willebrand Factor / Q000032:analysis / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents; D014841:von Willebrand Factor; D012310:Ristocetin; D005169:Factor VIII; D011239:Prednisolone